RUSSELL MILLER: Open Payments
NPI 1013455922 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$917 in 41 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $917
Food & beverage: $917
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| UCB, Inc. | 3 | $64 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Biogen, Inc. | 2 | $49 |
| Orexo US, Inc. | 2 | $49 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $44 |
| ARGENX US, INC. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
Products named: REXULTI, CAPLYTA, PURIFIED CORTROPHIN GEL, Zubsolv, VYVGART HYTRULO, PONVORY, SUBLOCADE, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
